CME Group Statistics
Total Valuation
CME Group has a market cap or net worth of $97.10 billion. The enterprise value is $99.37 billion.
| Market Cap | 97.10B |
| Enterprise Value | 99.37B |
Important Dates
The last earnings date was Wednesday, April 23, 2025, before market open.
| Earnings Date | Apr 23, 2025 |
| Ex-Dividend Date | Jun 9, 2025 |
Share Statistics
CME Group has 360.36 million shares outstanding. The number of shares has increased by 0.12% in one year.
| Current Share Class | 360.36M |
| Shares Outstanding | 360.36M |
| Shares Change (YoY) | +0.12% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 0.30% |
| Owned by Institutions (%) | 91.14% |
| Float | 358.89M |
Valuation Ratios
The trailing PE ratio is 27.12 and the forward PE ratio is 23.78. CME Group's PEG ratio is 3.84.
| PE Ratio | 27.12 |
| Forward PE | 23.78 |
| PS Ratio | 16.29 |
| Forward PS | 14.74 |
| PB Ratio | 3.78 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 25.38 |
| P/OCF Ratio | 24.80 |
| PEG Ratio | 3.84 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.49, with an EV/FCF ratio of 25.97.
| EV / Earnings | 27.75 |
| EV / Sales | 15.84 |
| EV / EBITDA | 22.49 |
| EV / EBIT | 24.33 |
| EV / FCF | 25.97 |
Financial Position
The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.14.
| Current Ratio | 1.02 |
| Quick Ratio | 0.02 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 0.85 |
| Debt / FCF | 0.99 |
| Interest Coverage | 25.11 |
Financial Efficiency
Return on equity (ROE) is 13.39% and return on invested capital (ROIC) is 8.26%.
| Return on Equity (ROE) | 13.39% |
| Return on Assets (ROA) | 1.76% |
| Return on Invested Capital (ROIC) | 8.26% |
| Return on Capital Employed (ROCE) | 11.22% |
| Revenue Per Employee | $1.67M |
| Profits Per Employee | $952,473 |
| Employee Count | 3,760 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CME Group has paid $1.05 billion in taxes.
| Income Tax | 1.05B |
| Effective Tax Rate | 22.38% |
Stock Price Statistics
The stock price has increased by +29.59% in the last 52 weeks. The beta is 0.47, so CME Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | +29.59% |
| 50-Day Moving Average | 264.61 |
| 200-Day Moving Average | 235.86 |
| Relative Strength Index (RSI) | 49.23 |
| Average Volume (20 Days) | 2,095,303 |
Short Selling Information
The latest short interest is 5.03 million, so 1.40% of the outstanding shares have been sold short.
| Short Interest | 5.03M |
| Short Previous Month | 4.96M |
| Short % of Shares Out | 1.40% |
| Short % of Float | 1.40% |
| Short Ratio (days to cover) | 1.53 |
Income Statement
In the last 12 months, CME Group had revenue of $6.27 billion and earned $3.58 billion in profits. Earnings per share was $9.94.
| Revenue | 6.27B |
| Gross Profit | 6.27B |
| Operating Income | 4.09B |
| Pretax Income | 4.25B |
| Net Income | 3.58B |
| EBITDA | 4.42B |
| EBIT | 4.09B |
| Earnings Per Share (EPS) | $9.94 |
Balance Sheet
The company has $1.52 billion in cash and $3.80 billion in debt, giving a net cash position of -$2.28 billion or -$6.32 per share.
| Cash & Cash Equivalents | 1.52B |
| Total Debt | 3.80B |
| Net Cash | -2.28B |
| Net Cash Per Share | -$6.32 |
| Equity (Book Value) | 27.03B |
| Book Value Per Share | 75.16 |
| Working Capital | 2.03B |
Cash Flow
In the last 12 months, operating cash flow was $3.91 billion and capital expenditures -$88.40 million, giving a free cash flow of $3.83 billion.
| Operating Cash Flow | 3.91B |
| Capital Expenditures | -88.40M |
| Free Cash Flow | 3.83B |
| FCF Per Share | $10.62 |
Margins
Gross margin is 100.00%, with operating and profit margins of 65.11% and 57.81%.
| Gross Margin | 100.00% |
| Operating Margin | 65.11% |
| Pretax Margin | 74.48% |
| Profit Margin | 57.81% |
| EBITDA Margin | 70.43% |
| EBIT Margin | 65.11% |
| FCF Margin | 60.98% |
Dividends & Yields
This stock pays an annual dividend of $10.60, which amounts to a dividend yield of 3.93%.
| Dividend Per Share | $10.60 |
| Dividend Yield | 3.93% |
| Dividend Growth (YoY) | 8.72% |
| Years of Dividend Growth | 6 |
| Payout Ratio | 106.64% |
| Buyback Yield | -0.12% |
| Shareholder Yield | 3.82% |
| Earnings Yield | 3.69% |
| FCF Yield | 3.94% |
Analyst Forecast
The average price target for CME Group is $255.44, which is -5.20% lower than the current price. The consensus rating is "Hold".
| Price Target | $255.44 |
| Price Target Difference | -5.20% |
| Analyst Consensus | Hold |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | 4.65% |
| EPS Growth Forecast (5Y) | 8.35% |
Stock Splits
The last stock split was on July 23, 2012. It was a forward split with a ratio of 5:1.
| Last Split Date | Jul 23, 2012 |
| Split Type | Forward |
| Split Ratio | 5:1 |
Scores
CME Group has an Altman Z-Score of 0.55 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.55 |
| Piotroski F-Score | 6 |